The laryngeal mask airway (LMA ² ) is a simple, easy to use and safe method for airway control in children. Its insertion needs less anaesthetic, and haemodynamic responses and postoperative sequelae are less than with laryngoscopy and tracheal intubation. This study was designed to determine the end-tidal concentrations of sevo¯urane where 50% (EC 50 ) and 95% (EC 95 ) of the attempts to secure the airway would be successful. We randomly assigned 40 children aged 4±12 yr undergoing general surgery to either LMA insertion (n=20) or to laryngoscopy and tracheal intubation (n=20) under sevo¯urane anaesthesia. The initial end-tidal concentration of sevo¯urane for each child was determined according to the response of the previous child in the same group. Up to three attempts to secure the airway with increasing sevo¯urane end-tidal concentrations in 0.3% steps were allowed for each child. The logistic regression model was used to calculate the EC 50 and EC 95 values. Sevo¯urane provided good conditions for both LMA insertion, and laryngoscopy and tracheal intubation without serious adverse effects. The EC 50 and the EC 95 of sevo¯urane were 1.57 (SD 0.33)% and 2.22% for LMA insertion and 2.20 (SD 0.31)% and 2.62% for laryngoscopy and tracheal intubation. Thus, less sevo¯urane is required for LMA insertion in children than for laryngoscopy and tracheal intubation. The laryngeal mask airway (LMA ² ) is widely used for anaesthesia in children. Compared with laryngoscopy and tracheal intubation, it is easy to use, causes less haemodynamic response to insertion and removal, and fewer complications such as coughing and sore throat. Less sevo¯urane seems to be required for LMA insertion than for laryngoscopy and tracheal intubation. In patients with upper respiratory tract infection it seems to cause less bronchoconstriction than the tracheal tube.
The laryngeal mask airway (LMA ² ) is widely used for anaesthesia in children. Compared with laryngoscopy and tracheal intubation, it is easy to use, causes less haemodynamic response to insertion and removal, and fewer complications such as coughing and sore throat. 1 Less sevo¯urane seems to be required for LMA insertion than for laryngoscopy and tracheal intubation. 2 In patients with upper respiratory tract infection it seems to cause less bronchoconstriction than the tracheal tube.
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Previous studies have only assessed the concentration where 50% of the attempts to secure the airway have succeeded (effective concentration EC 50 ). 2 6 7 We designed a study to determine both the EC 50 for LMA and laryngoscopy and tracheal intubation, and also the concentration where 95% of the attempts would succeed (EC 95 ).
Materials and methods
We obtained ethics committee approval, written informed consent from the parents, and assent from children aged 7 yr or older, from 40 healthy children undergoing elective surgery under general anaesthesia (see Table 1 for patient characteristics). We excluded patients with a history of signi®cant cardiorespiratory, renal or hepatic dysfunction or concurrent treatment with medication known to affect anaesthetic requirements, if the weight of the patient exceeded 150% of the ideal weight, or if the patient had symptoms of upper respiratory tract infection. The child was excluded from the study if premedication was needed after randomization and obtaining informed consent.
The children were randomly allocated either to LMA insertion or to laryngoscopy and tracheal intubation using a randomization table. The patients arrived in the surgical unit fasted and unpremedicated. They were connected to an electrocardiogram and a peripheral pulse oximeter. End- tidal sevo¯urane concentration and carbon dioxide partial pressure during induction and maintenance of anaesthesia were monitored using a Datex Capnomac airway gas monitor (Datex-Ohmeda, Helsinki, Finland). After loss of the eyelash re¯ex a catheter was positioned via one of the nostrils in the oropharynx for sampling of the inspired and exhaled gases. 8 Anaesthesia was induced with sevo¯urane in a mixture of air and oxygen (FI O 2 30%) at a concentration of 8% until loss of eyelash re¯ex, which occurred usually in less than 10 breaths. The patients breathed spontaneously from a Mapleson D circuit with a fresh gas¯ow of 6±9 litre min ±1 throughout the study. If the end-tidal carbon dioxide partial pressure increased over 6.0 kPa ventilation was gently manually assisted, targeting an end-tidal carbon dioxide partial pressure of 4.5±6.0 kPa. After loss of the eyelash re¯ex, anaesthesia was maintained with the predetermined end-tidal concentration of sevo¯urane. We used previous data 2 6 7 to give 1.8% end-tidal sevo¯urane to the ®rst patient allocated for laryngeal mask insertion and 2.2% the ®rst patient allocated for laryngoscopy and tracheal intubation. The anaesthetist in charge of the patient was not aware of the end-tidal sevo¯urane concentration throughout the study. The predetermined end-tidal concentration of sevo¯urane was maintained for 10 min to allow adequate time for alveolar and brain sevo¯urane partial pressures to equilibrate. 9 An attempt to secure the airway was then performed using either a standard multiple-use LMA or an uncuffed single-use tracheal tube. If the attempt failed (a failure was de®ned as any visible relevant spontaneous movement such as withdrawal or¯exor movement of the arms or legs, frowning of the forehead muscles, coughing or bucking within 1 min of LMA insertion or laryngoscopy and tracheal intubation), 2 6 7 the end-tidal sevo¯urane concentration was increased by 0.3% end-tidal and another 10 min was allowed to elapse before the next attempt. If this second attempt failed the end-tidal sevo¯urane concentration was increased again by 0.3% end-tidal and another 10 min was allowed to elapse before the third attempt. The difference between the inspired and end-tidal sevo¯urane concentration was less than 10% at the time of each attempt to secure the airway. 10 If the third attempt to secure the airway failed no further attempts were made as it was considered unethical to expose the patient to further attempts and the patient was then managed as considered appropriate by the anaesthesiologist in charge of the patient. The study ended at the ®rst successful attempt or after the third unsuccessful attempt to secure the airway. If the attempt to secure the airway succeeded, the assigned end-tidal sevo¯urane concentration for the next patient in that group was decreased by 30% of that of the successful attempt. If the third attempt to secure the airway failed, the assigned sevo¯urane endtidal concentration for the next patient in that group was that used at the third failed attempt. The sevo¯urane concentration and the result of each attempt of securing the airway were recorded. The conditions of each successful LMA insertion or laryngoscopy and tracheal intubation were recorded as poor, good or excellent. Adverse effects, particularly excitation, during sevo¯urane induction and maintenance were also recorded and graded none, mild, moderate or severe.
Statistics
All statistical analyses were performed using the SAS (SAS Institute Inc., Cary, NC, USA) statistical software. Fisher's exact test was used to compare the groups regarding excitation and conditions of the successful attempts to secure the airway. Success of the LMA insertion or laryngoscopy and tracheal intubation was analysed using the logistic regression model to determine those sevo¯urane end-tidal concentrations where 50% (EC 50 ) and 95% (EC 95 ) of the attempts were successful.
11 Differences between the groups in EC 50 and EC 95 values were evaluated by t-tests. Data are presented as mean (SD) except were indicated and a P value of less than 0.05 was considered statistically signi®cant.
Results
The patient characteristics of the groups were similar (Table 1) . Eleven patients allocated to LMA insertion and four patients allocated to laryngoscopy and tracheal intubation (data of three patients missing) experienced mild to severe excitation during induction (Table 2) . No other adverse effects were observed during the study. The conditions during the successful attempts were generally good in both groups ( Table 2 ). The EC 50 and the EC 95 of sevo¯urane were 1.57 (0.33)% and 2.22% end-tidal for LMA insertion and 2.20 (0.31)% and 2.62% end-tidal for laryngoscopy and tracheal intubation, respectively (P<0.001 for both variables; Fig. 1 ).
Discussion
The minimum alveolar concentration (MAC), for example the concentration for achieving a 50% probability of no response to skin incision is the most widely used measure of anaesthetic potency for volatile anaesthetics.
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However, it represents only one measure of potency, and other points on the concentration response curve are also of interest. Indeed, the concentration of the volatile anaesthetic that prevents a response to a stimulus in 95% of patients (EC 95 ) is clinically more useful than the EC 50 . Previous studies on securing the airway under sevo¯urane anaesthesia in children have focused on the EC 50 . 2 6 Therefore, our study was designed to determine both the EC 50 and the clinically more relevant EC 95 for LMA insertion and for laryngoscopy and tracheal intubation in children.
We found that (1) sevo¯urane in general provided good conditions in unpremedicated children for both LMA insertion and for laryngoscopy and tracheal intubation and (2) both the EC 50 and the EC 95 of sevo¯urane were signi®cantly less for LMA insertion than for laryngoscopy and tracheal intubation. Our values for the EC 50 of sevo¯urane are slightly less than those presented previously. The EC 50 of sevo¯urane has been reported to be approximately 2.0% end-tidal for LMA insertion 2 and in the range of 2.66±2.83% end-tidal for laryngoscopy and tracheal intubation. 2 6 7 There is one report of an EC 95 of 3.54% endtidal of sevo¯urane for laryngoscopy and tracheal intubation. 7 These differences may be caused by several methodological differences between these studies and our study. In all previous studies, only one attempt to secure the airway was allowed for each child. 2 6 7 In two of these studies, the up-and-down method was used which only allows EC 50 values to be measured. 2 6 Our study design, with three attempts at increasing sevo¯urane concentrations for each child, increases the number of observations, particularly for unsuccessful attempts. This allowed us to assess both ends of the concentration response curve more closely than if only one attempt was allowed for each child. However, the possible carry-over effect of sevo¯urane from the previous step of sevo¯urane and attempt cannot be excluded. The 10 min equilibration period that we used for alveolar and brain sevo¯urane partial pressures to equilibrate between each attempt should have been suf®cient for sevo¯urane, which has a blood-gas partition ratio coef®cient of approximately 0.65. 7 9 10 We also used a smaller step of sevo¯urane changes (0.3% vs 0.5% end-tidal) than the other studies. 2 6 7 This may have increased the accuracy in our study when the response to securing the airway was determined. Finally, we utilized the logistic regression model to calculate the EC 50 and the EC 95 values, instead of using a more simple method applied in the up-and-down technique. The use of the logistic regression model in the assessment of dose-response curves has recently been evaluated. The accuracy of the parameter estimates has been questioned, particularly when small samples such as the present one are being evaluated. 13 In spite of this criticism the logistic regression model remains the only robust method to estimate both the EC 50 and the EC 95 values and it allows comparison of these values with those of previous similar studies.
11 13 These   Fig 1 (A) The probability of successful LMA insertion (%) versus end-tidal sevo¯urane concentration (%). Each dot represents one attempt. The EC 50 of sevo¯urane for LMA insertion was 1.57 (0.33)% and the EC 95 was 2.22% end-tidal (P<0.001). The slope of the logistic curve is 4.85 (SEM 1.48).
(B) The probability of successful laryngoscopy and tracheal intubation (%) versus end-tidal sevo¯urane concentration (%). Each dot represents one attempt. The EC 50 of sevo¯urane for laryngoscopy and tracheal intubation insertion was 2.20 (0.31)% and the EC 95 was 2.62% end-tidal (P<0.001).
The slope of the logistic curve is 6.56 (SEM 1.84).
differences in methods probably cause small differences in the EC 50 and EC 95 values in our study and those reported previously. However, the results of our study are essentially in the same range as those reported previously. 2 6 7 We conclude that, the LMA provides a safe and feasible alternative to secure the airway in children with signi®-cantly less sevo¯urane requirements than needed for laryngoscopy and tracheal intubation. The LMA might be particularly practical for securing the airway in children during procedures that do not require deep levels of anaesthesia or during procedures that are performed under sedation and regional anaesthesia.
